| GP10045-25mg |
|
— |
|
0 |
— |
|
|
|
| GP10045-10mg |
|
— |
|
0 |
— |
|
|
|
| GP10045-5mg |
|
— |
|
0 |
— |
|
|
|
| GP10044-25mg |
|
— |
IgG light chain variable region [Homo sapiens]/IgM/kappa antibody [Mus musculus]
|
0 |
— |
|
|
|
| GP10044-10mg |
|
— |
IgG light chain variable region [Homo sapiens]/IgM/kappa antibody [Mus musculus]
|
0 |
— |
|
|
|
| GP10044-5mg |
|
— |
IgG light chain variable region [Homo sapiens]/IgM/kappa antibody [Mus musculus]
|
0 |
— |
|
|
|
| GP10044-1mg |
|
— |
IgG light chain variable region [Homo sapiens]/IgM/kappa antibody [Mus musculus]
|
0 |
— |
|
|
|
| GP10043-25mg |
|
100111-07-7 |
GnRH Associated Peptide (GAP) (1-13), human
|
0 |
— |
|
|
|
| GP10043-10mg |
|
100111-07-7 |
GnRH Associated Peptide (GAP) (1-13), human
|
0 |
— |
|
|
|
| GP10043-5mg |
|
100111-07-7 |
GnRH Associated Peptide (GAP) (1-13), human
|
0 |
— |
|
|
|
| GP10043-1mg |
|
100111-07-7 |
GnRH Associated Peptide (GAP) (1-13), human
|
0 |
— |
|
|
|
| GP10042-25mg |
|
— |
|
0 |
— |
|
|
|
| GP10042-10mg |
|
— |
|
0 |
— |
|
|
|
| GP10042-5mg |
|
— |
|
0 |
— |
|
|
|
| GP10042-1mg |
|
— |
|
0 |
— |
|
|
|
| GP10040-25mg |
|
— |
heparin cofactor II precursor (SERPIND1) fragment [Homo sapiens]
|
0 |
— |
|
|
|
| GP10040-10mg |
|
— |
heparin cofactor II precursor (SERPIND1) fragment [Homo sapiens]
|
0 |
— |
|
|
|
| GP10040-5mg |
|
— |
heparin cofactor II precursor (SERPIND1) fragment [Homo sapiens]
|
0 |
— |
|
|
|
| GP10040-1mg |
|
— |
heparin cofactor II precursor (SERPIND1) fragment [Homo sapiens]
|
0 |
— |
|
|
|
| GP10039-25mg |
|
— |
eukaryotic translation initiation factor 3
|
0 |
— |
|
|
|
